Prostate cancer continues to be a topic of great debate across the world both especially in the medical community. With the rising need for increased education & awareness, improved treatment options and sharing of knowledge, The Punjab Institute of Medical Sciences, Jalandhar organized a “Multidisciplinary Uro-Oncology meet on Prostate Cancer” held on 26 April 2015.
The aim of the meet was to bring together Urologist, Uro-oncologist, Surgical-oncologist, Radiation oncologist, Medical oncologist and most importantly General Surgeons and General Physicians to discuss all facets of Prostate Cancer Management, treatment and scientific advancement. The topics for discussion in scientific meet were as follows -:
[zozo_icons icon=”fa fa-check” icontype=”none” iconstyle=”light” size=”small” iconcolor=”” iconbgcolor=”” bordercolor=”” borderwidth=”” animation_type=”none” animation_delay=”500″] Translational Research and Pathology: What is New?
[zozo_icons icon=”fa fa-check” icontype=”none” iconstyle=”light” size=”small” iconcolor=”” iconbgcolor=”” bordercolor=”” borderwidth=”” animation_type=”none” animation_delay=”500″] Prostate Cancer Screening by PSA:- Indian Scenario Yes, No or May be?
[zozo_icons icon=”fa fa-check” icontype=”none” iconstyle=”light” size=”small” iconcolor=”” iconbgcolor=”” bordercolor=”” borderwidth=”” animation_type=”none” animation_delay=”500″] Diagnosis and Staging Work up :- A Patient tailored approach
[zozo_icons icon=”fa fa-check” icontype=”none” iconstyle=”light” size=”small” iconcolor=”” iconbgcolor=”” bordercolor=”” borderwidth=”” animation_type=”none” animation_delay=”500″] Early Prostate Cancer –Surgery or Radiotherapy
[zozo_icons icon=”fa fa-check” icontype=”none” iconstyle=”light” size=”small” iconcolor=”” iconbgcolor=”” bordercolor=”” borderwidth=”” animation_type=”none” animation_delay=”500″] High risk /Locally advanced Prostate Cancer :- New targets and treatment on the horizon
[zozo_icons icon=”fa fa-check” icontype=”none” iconstyle=”light” size=”small” iconcolor=”” iconbgcolor=”” bordercolor=”” borderwidth=”” animation_type=”none” animation_delay=”500″] Hormone Responsive Metastatic Prostate Cancer
[zozo_icons icon=”fa fa-check” icontype=”none” iconstyle=”light” size=”small” iconcolor=”” iconbgcolor=”” bordercolor=”” borderwidth=”” animation_type=”none” animation_delay=”500″] Rapidly evolving option in the management of Castration resistant Prostate Cancer
[zozo_icons icon=”fa fa-check” icontype=”none” iconstyle=”light” size=”small” iconcolor=”” iconbgcolor=”” bordercolor=”” borderwidth=”” animation_type=”none” animation_delay=”500″] Optimizing bone health in patients with prostate cancer
[zozo_icons icon=”fa fa-check” icontype=”none” iconstyle=”light” size=”small” iconcolor=”” iconbgcolor=”” bordercolor=”” borderwidth=”” animation_type=”none” animation_delay=”500″] Best management strategies
The CME came to an end with an insightful panel discussion.